SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-016023
Filing Date
2011-01-27
Accepted
2011-01-27 16:32:37
Documents
6
Period of Report
2011-01-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27827
2 AMENDED AND RESTATED CERTIFICATE OF DESIGNATION OF PREFERENCES dex31.htm EX-3.1 147811
3 FORM OF CLASS A-1 COMMON STOCK PURCHASE WARRANT dex41.htm EX-4.1 41845
4 FORM OF CLASS A-2 COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 42110
5 FORM OF CLASS B-1 COMMON STOCK PURCHASE WARRANT dex43.htm EX-4.3 40649
6 AGREEMENT DATED JANUARY 21, 2011 BETWEEN THE COMPANY AND 10X FUND dex101.htm EX-10.1 23349
  Complete submission text file 0001193125-11-016023.txt   325202
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033
PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 11552578
SIC: 2834 Pharmaceutical Preparations